U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746921) titled 'Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmental Disabilities' on July 13.
Brief Summary: Correct use of daily medications containing inhaled corticosteroids is key for asthma control, yet children with intellectual and developmental disabilities (IDD) face additional barriers to proper inhaler use. Smart inhalers, a novel technology that provides guidance and immediate feedback on inhaler use techniques, have been shown to enhance correct medication administration in the typically developing pediatric population, but their effectiveness has not been evaluated on the pediatric IDD populati...